Document is current
Any future updates will be listed below
-
Authors
Pennlund, Anna https://orcid.org/0000-0002-9700-2381
Esposito, Daniela
Bontell, Thomas Olsson
Skoglund, Thomas
Hallén, Tobias
Carén, Helena
Johannsson, Gudmundur
Olsson, Daniel S.
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Accepted: 22 January 2025
First Online: 22 February 2025
Declarations
:
: The study was approved by the Swedish Ethical Review Authority (Etikprövningsmyndigheten) (Dnr: 2019–04779).
: A.P., T.O.B., T.S., T.H., H.C., and G.J. has no conflict of interest to declare. D.E. has received lecture fees from Ipsen, Pfizer AB and Recordati Rare Disease. D.S.O. has been a consultant for Sandoz, Ipsen, and Pfizer; has received unrestricted grants from Sandoz and Pfizer; and is an employee at AstraZeneca as of 8 August 2021.
